Table of Contents Author Guidelines Submit a Manuscript
Sarcoma
Volume 2017, Article ID 2316839, 6 pages
https://doi.org/10.1155/2017/2316839
Clinical Study

Concurrent Imatinib and Radiation Therapy for Unresectable and Symptomatic Desmoid Tumors

1Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA, USA
2Department of Orthopaedic Surgery, Stanford University School of Medicine, Stanford, CA, USA
3Department of Radiology, Stanford University School of Medicine, Stanford, CA, USA
4Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA
5Department of Medicine, Division of Oncology, Stanford University School of Medicine, Stanford, CA, USA

Correspondence should be addressed to Kristen N. Ganjoo; ude.drofnats@oojnagk

Received 5 February 2017; Revised 23 April 2017; Accepted 4 June 2017; Published 5 July 2017

Academic Editor: Valerae O. Lewis

Copyright © 2017 Everett J. Moding et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Everett J. Moding, Lynn Million, Raffi Avedian, Pejman Ghanouni, Christian Kunder, and Kristen N. Ganjoo, “Concurrent Imatinib and Radiation Therapy for Unresectable and Symptomatic Desmoid Tumors,” Sarcoma, vol. 2017, Article ID 2316839, 6 pages, 2017. https://doi.org/10.1155/2017/2316839.